Conference Coverage

VIDEO: Health advisers boost type 2 diabetes adherence


 

REPORTING FROM AACE 2018

– A company that partners patients and health advisers claims to help patients with type 2 diabetes to manage their symptoms and lower their HbA1c levels.

The Pack Health program connects each patient with a health adviser, who contacts them five times a week using a mix of phone calls, text messages, and emails. The goals include helping patients to find clinicians in their area, make appointments, and adhere to treatment, Dhiren Patel, PharmD, medical director at Pack Health, said at the annual meeting of the American Association of Clinical Endocrinologists.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

In a prospective study of 756 type 2 diabetes patients, traditional modes of communication with a health coach were associated with a 1% decrease in HbA1c within 3 months and the reduction was maintained at 1 year. Patients lost an average of 5 pounds, and annual eye and foot exams increased by 17% and 19%, respectively.

Similar remote health coach initiatives are being used to help other patients with chronic health conditions as part of the Pack Health services, which Dr. Patel discussed in a video interview.

SOURCE: Patel D et al. AACE 2018. Abstract 1209.

Recommended Reading

VIDEO: First year after bariatric surgery critical for HbA1c improvement
MDedge Endocrinology
SCVD common in women with type 1 diabetes
MDedge Endocrinology
Trends in teen consumption of sports drinks are up and down
MDedge Endocrinology
Do “VILPs” signal a new era for viral endocrinology?
MDedge Endocrinology
VIDEO: Real-world findings on hybrid closed-loop insulin system
MDedge Endocrinology
Hematocrit improvement with SGLT2 inhibitor: Not just a diuretic effect?
MDedge Endocrinology
VIDEO: Diabetes patients achieve lipid goals on alirocumab
MDedge Endocrinology
VIDEO: Move beyond BMI to see obesity as a disease
MDedge Endocrinology
VIDEO: Canagliflozin’s HbA1c effect muted over time by placebo group effects
MDedge Endocrinology
Canagliflozin linked to lower HbA1c levels in younger patients
MDedge Endocrinology